.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Daiichi Sankyo
Novartis
Farmers Insurance
Colorcon
McKinsey
Boehringer Ingelheim
Fish and Richardson
Deloitte

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201404

« Back to Dashboard
NDA 201404 describes AMPICILLIN SODIUM, which is a drug marketed by Istituto Bio Ita Spa, Watson Labs Inc, Mylan Labs Ltd, Intl Medication, Consolidated Pharm, Sandoz, Hanford Gc, Antibiotice, Apothecon, Hospira Inc, Lilly, Sagent Pharms, Acs Dobfar Spa, West-ward Pharms Int, and Aurobindo Pharma, and is included in thirty-two NDAs. It is available from eighteen suppliers. Additional details are available on the AMPICILLIN SODIUM profile page.

The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are sixty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.

Summary for NDA: 201404

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 201404

Ingredient-typePenicillins

Suppliers and Packaging for NDA: 201404

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMPICILLIN SODIUM
ampicillin sodium
 INJECTABLE;INJECTION 201404 ANDA APP Pharmaceuticals, LLC 63323-404 63323-404-00 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (63323-404-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10GM BASE/VIAL
Approval Date:Dec 20, 2013TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Mallinckrodt
Medtronic
Deloitte
Dow
Johnson and Johnson
Novartis
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot